The glucagon-like peptide-1 receptor agonist exenatide does not yield improvement in measures of Parkinson disease severity.
It can be used treat essential tremor, Parkinson’s disease, epilepsy, and neuropathic pain through sound waves ...
GlobalData on MSN1d
SmartCella gains rights to advance cell therapy research for Parkinson’sThe company signed the agreement with Karolinska Institutet's Department of Cell and Molecular Biology professor Johan ...
The US Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in ...
From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, scientists were able to identify patterns of neurodegeneration and create metrics ...
HIV is a manageable chronic condition. With treatment, people living with HIV can have long and healthy lives. However, if left untreated, it can cause a weakened immune system or acquired immune ...
Researchers at Karolinska Institutet have discovered new insights into brain changes in Parkinson's disease using advanced ...
Fingernail-sized vibrating gadgets, similar to the tiny devices that make your cellphone buzz, could help people with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback